Testing for flu, malarial drug resistance, and identifying the Bali bombers are all outcomes of an Australia-Indonesia medical research initiative that begun in 1997 and continues today.
The original Australia-Indonesia Medical Research Initiative agreement between the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne and the Eijkman Institute for Molecular Biology in Jakarta was conceived and funded by the Indonesian Minister of Research and Technology and the Australian Government, and designed to boost the capacity of the Indonesian labs while enabling more transfer of ideas and skills between the two countries.
“Dengue has a significant impact on both Australia and Indonesia—the disease is hyper-endemic in Indonesia and affects the daily life of people living in the country,” says Dr Tedjo Sasmono of the Eijkman Institute for Molecular Biology in Jakarta.
Their researchers have been working with The University of Queensland to create a new way to screen blood for dengue virus.
It’s the result of a joint-research project on dengue diagnostics, initiated in 2015 and funded by an Australian Research Council (ARC) Linkage grant in collaboration with the Australian Red Cross Blood Service.
